Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C4VG
|
||||
Former ID |
DNC014410
|
||||
Drug Name |
4-phospho-D-erythronate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C4H9O8P
|
||||
Canonical SMILES |
C(C(C(C(=O)O)O)O)OP(=O)(O)O
|
||||
InChI |
1S/C4H9O8P/c5-2(3(6)4(7)8)1-12-13(9,10)11/h2-3,5-6H,1H2,(H,7,8)(H2,9,10,11)/t2-,3-/m1/s1
|
||||
InChIKey |
ZCZXOHUILRHRQJ-PWNYCUMCSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 6-phosphogluconate dehydrogenase, decarboxylating | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Pentose phosphate pathway | ||||
Pentose phosphate pathway (oxidative branch) | |||||
KEGG Pathway | Pentose phosphate pathway | ||||
Glutathione metabolism | |||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
Carbon metabolism | |||||
PANTHER Pathway | Pentose phosphate pathway | ||||
PathWhiz Pathway | Warburg Effect | ||||
WikiPathways | NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | |||||
Metabolism of carbohydrates | |||||
Pentose Phosphate Pathway | |||||
References | |||||
REF 1 | Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase. Bioorg Med Chem. 2010 Jul 15;18(14):5056-62. doi: 10.1016/j.bmc.2010.05.077. Epub 2010 Jun 9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.